Skin rejuvenation in facial surgery.
The treatment of the aging face has evolved to increasingly incorporate minimally office-based procedures. The importance of recognizing and treating facial rhytids has always been recognized as important, but an increasing number of modalities have been developed for this purpose. Similarly, there has been an increase of emphasis in the recognition of dyschromias, solar keratoses, and other skin abnormalities. In this article, an overview of many of the minimally invasive office-based procedures that we favor in our practice will be briefly reviewed.
Atkins
Debra
D
Atlanta Medical Day Spa, Marietta, Georgia, USA.
Frodel
John
J
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002615:Chemexfoliation / Q000379:methods; D003094:Collagen / Q000627:therapeutic use; D003869:Dermabrasion / Q000379:methods; D005260:Female; D006204:Hair Removal / Q000379:methods; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D007642:Keratosis / Q000601:surgery; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010347:Patient Care Planning; D010789:Phototherapy / Q000379:methods; D010859:Pigmentation Disorders / Q000601:surgery; D012060:Rejuvenation; D015361:Rhytidoplasty / Q000379:methods*; D015595:Skin Aging / Q000473:pathology*; D017445:Skin Diseases, Vascular / Q000601:surgery
D007641:Keratolytic Agents; D009465:Neuromuscular Agents; D003094:Collagen; D019274:Botulinum Toxins, Type A